ICD-10-CM Billable Code

F18.959

Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Inhalant use refers to the inhalation of volatile substances to achieve a psychoactive effect. When such use leads to a psychotic disorder, it signifies a serious mental health condition triggered by inhalant consumption. The ICD-10 code F18.959 describes unspecified inhalant use associated with inhalant-induced psychotic disorder, highlighting a broad diagnosis without pinpointing specific inhalants or symptoms.

Causes & Symptoms

Clinical Causes: Intentional or accidental inhalation of volatile substances like glue, paint thinner, gasoline, or aerosol sprays. Habitual misuse of inhalants, often by adolescents or young adults seeking a quick high. Underlying mental health issues or substance dependence tendencies. Environmental factors, including easy access to volatile substances or peer pressure. Psychosocial stressors prompting individuals to experiment with inhalants as a coping mechanism.

Key Symptoms: Hallucinations, such as seeing or hearing things that aren't present. Delusional thinking or false beliefs. Disorganized thoughts or speech. Confusion or disorientation. Emotional disturbances like agitation or depression. Physical symptoms, including dizziness, nausea, or coordination problems. Possible loss of consciousness in severe cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a detailed clinical interview, assessment of the patient's substance use history, and examination of mental state. Healthcare providers may perform laboratory tests or toxicology screenings to detect inhalants in the system. Due to the unspecified nature of the condition, medical evaluations aim to rule out other causes of psychotic symptoms and confirm the link to inhalant use.

Treatment Protocols: Treatment strategies focus on addressing both the substance use and the psychotic symptoms. This may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F18.959 a billable ICD-10 code?
Yes, F18.959 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F18.959?
Clinical documentation must specify the nature of Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference